The maqui market in North America is experiencing growth, driven by the use of the fruit in functional foods and beverages due to increasing health awareness. Maqui is rich in antioxidants and is ideal for the immune system, making it a popular ingredient in the pharmaceutical and nutraceutical sector. The market is expected to reach $26.93 million in 2030 at a CAGR of 11.3% from 2022 to 2030. The market is segmented into fresh and processed, as well as organic and conventional. In 2022, the functional food and beverage segment held the largest share of the North American maqui market, with the United States dominating the market that year.